학술논문
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial
Document Type
Article
Author
Source
In: Diabetologia . (Diabetologia, May 2024, 67(5):811-821)
Subject
Language
English
ISSN
14320428
0012186X
0012186X